131 related articles for article (PubMed ID: 36470093)
21. Bone versus soft-tissue sarcomas in the elderly.
Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
[TBL] [Abstract][Full Text] [Related]
22. Age-related sarcoma patient experience: results from a national survey in England.
Younger E; Husson O; Bennister L; Whelan J; Wilson R; Roast A; Jones RL; van der Graaf WT
BMC Cancer; 2018 Oct; 18(1):991. PubMed ID: 30333006
[TBL] [Abstract][Full Text] [Related]
23. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
[TBL] [Abstract][Full Text] [Related]
24. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
[TBL] [Abstract][Full Text] [Related]
25. Proteomic features of soft tissue tumours in adolescents and young adults.
Tam YB; Low K; Ps H; Chadha M; Burns J; Wilding CP; Arthur A; Chen TW; Thway K; Sadanandam A; Jones RL; Huang PH
Commun Med (Lond); 2024 May; 4(1):93. PubMed ID: 38762630
[TBL] [Abstract][Full Text] [Related]
26. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
[TBL] [Abstract][Full Text] [Related]
27. Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time.
Mata Fernández C; Gutierrez Carrasco N; Juan Ribelles A; Hindi Muñiz N; Estival González A; Rubio San Simón A; Portellano LC; Medina SR; Morales CV
Clin Transl Oncol; 2022 Dec; 24(12):2475-2479. PubMed ID: 35988093
[TBL] [Abstract][Full Text] [Related]
28. Soft-tissue sarcoma in adolescents and young adults compared with older adults: A report among 5000 patients from the Scandinavian Sarcoma Group Central Register.
Papworth KE; Arroyo VM; Styring E; Zaikova O; Melin BS; Lupo PJ
Cancer; 2019 Oct; 125(20):3595-3602. PubMed ID: 31287163
[TBL] [Abstract][Full Text] [Related]
29. Management of sarcomas in children, adolescents and adults: Interactions in two different age groups under the umbrellas of GSF-GETO and SFCE, with the support of the NETSARC+ network.
Bompas E; Martin V; Meniai F; Toulmonde M; Marec-Berard P; Claude L; Ducimetiere F; Chargari C; Minard-Colin V; Corradini N; Laurence V; Piperno-Neumann S; Defachelles AS; Bernier V; Italiano A; Orbach D; Blay JY; Gaspar N; Berlanga P
Bull Cancer; 2021 Feb; 108(2):163-176. PubMed ID: 33455736
[TBL] [Abstract][Full Text] [Related]
30. ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review.
Andritsch E; Beishon M; Bielack S; Bonvalot S; Casali P; Crul M; Delgado Bolton R; Donati DM; Douis H; Haas R; Hogendoorn P; Kozhaeva O; Lavender V; Lovey J; Negrouk A; Pereira P; Roca P; de Lempdes GR; Saarto T; van Berck B; Vassal G; Wartenberg M; Yared W; Costa A; Naredi P
Crit Rev Oncol Hematol; 2017 Feb; 110():94-105. PubMed ID: 28109409
[TBL] [Abstract][Full Text] [Related]
31. Survival of childhood and adolescent/young adult (AYA) cancer patients in Ireland during 1994-2013: comparisons by age.
Alken S; Owens C; Gilham C; Grant C; Pears J; Deady S; O'Marcaigh A; Capra M; O'Mahony D; Smith O; Walsh PM
Ir J Med Sci; 2020 Nov; 189(4):1223-1236. PubMed ID: 32424602
[TBL] [Abstract][Full Text] [Related]
32. Overview of sarcomas in the adolescent and young adult population.
Herzog CE
J Pediatr Hematol Oncol; 2005 Apr; 27(4):215-8. PubMed ID: 15838394
[TBL] [Abstract][Full Text] [Related]
33. BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
Kao YC; Owosho AA; Sung YS; Zhang L; Fujisawa Y; Lee JC; Wexler L; Argani P; Swanson D; Dickson BC; Fletcher CDM; Antonescu CR
Am J Surg Pathol; 2018 May; 42(5):604-615. PubMed ID: 29300189
[TBL] [Abstract][Full Text] [Related]
34. Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults.
Kube SJ; Blattmann C; Bielack SS; Kager L; Kaatsch P; Kühne T; Sorg B; Kevric M; Jabar S; Hallmen E; Sparber-Sauer M; Klingebiel T; Koscielniak E; Dirksen U; Hecker-Nolting S; Gerß JWO
Cancer; 2022 May; 128(9):1787-1800. PubMed ID: 35195899
[TBL] [Abstract][Full Text] [Related]
35. European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy.
Touati N; Schöffski P; Litière S; Judson I; Sleijfer S; van der Graaf WT; Italiano A; Isambert N; Gil T; Blay JY; Stark D; Brodowicz T; Marréaud S; Gronchi A
Clin Oncol (R Coll Radiol); 2018 Jul; 30(7):448-454. PubMed ID: 29550245
[TBL] [Abstract][Full Text] [Related]
36. PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma.
Scheinberg T; Lomax A; Tattersall M; Thomas D; McCowage G; Sullivan M; Karim R; Luk PP; Mahar A; Bonar F; Bhadri VA
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1327. PubMed ID: 33314769
[TBL] [Abstract][Full Text] [Related]
37. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I;
Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349
[TBL] [Abstract][Full Text] [Related]
38. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
[TBL] [Abstract][Full Text] [Related]
39. Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
Benson C; Ray-Coquard I; Sleijfer S; Litière S; Blay JY; Le Cesne A; Papai Z; Judson I; Schöffski P; Chawla S; Gil T; Piperno-Neumann S; Marréaud S; Dewji MR; van der Graaf WTA
Gynecol Oncol; 2016 Jul; 142(1):89-94. PubMed ID: 27012429
[TBL] [Abstract][Full Text] [Related]
40. Length of stay and treatment-related complications are similar in pediatric and AYA patients with bone sarcoma in United States children's hospitals.
Audino AN; Yeager ND; Asti L; Miao Y; O'Brien SH
Pediatr Blood Cancer; 2013 Mar; 60(3):415-9. PubMed ID: 22706952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
